1. Home
  2. LGND vs JOE Comparison

LGND vs JOE Comparison

Compare LGND & JOE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGND
  • JOE
  • Stock Information
  • Founded
  • LGND 1987
  • JOE 1936
  • Country
  • LGND United States
  • JOE United States
  • Employees
  • LGND N/A
  • JOE N/A
  • Industry
  • LGND Biotechnology: Pharmaceutical Preparations
  • JOE Homebuilding
  • Sector
  • LGND Health Care
  • JOE Real Estate
  • Exchange
  • LGND Nasdaq
  • JOE Nasdaq
  • Market Cap
  • LGND 2.3B
  • JOE 2.7B
  • IPO Year
  • LGND 1992
  • JOE N/A
  • Fundamental
  • Price
  • LGND $120.43
  • JOE $46.44
  • Analyst Decision
  • LGND Strong Buy
  • JOE
  • Analyst Count
  • LGND 6
  • JOE 0
  • Target Price
  • LGND $145.00
  • JOE N/A
  • AVG Volume (30 Days)
  • LGND 107.6K
  • JOE 295.7K
  • Earning Date
  • LGND 11-07-2024
  • JOE 10-23-2024
  • Dividend Yield
  • LGND N/A
  • JOE 1.21%
  • EPS Growth
  • LGND 160.46
  • JOE N/A
  • EPS
  • LGND 2.47
  • JOE 1.17
  • Revenue
  • LGND $152,422,000.00
  • JOE $385,141,000.00
  • Revenue This Year
  • LGND $26.86
  • JOE N/A
  • Revenue Next Year
  • LGND $13.16
  • JOE N/A
  • P/E Ratio
  • LGND $48.80
  • JOE $40.45
  • Revenue Growth
  • LGND N/A
  • JOE 5.76
  • 52 Week Low
  • LGND $67.53
  • JOE $46.21
  • 52 Week High
  • LGND $129.90
  • JOE $64.69
  • Technical
  • Relative Strength Index (RSI)
  • LGND 52.94
  • JOE 26.31
  • Support Level
  • LGND $113.39
  • JOE $46.84
  • Resistance Level
  • LGND $124.03
  • JOE $47.81
  • Average True Range (ATR)
  • LGND 5.31
  • JOE 1.09
  • MACD
  • LGND -0.50
  • JOE -0.14
  • Stochastic Oscillator
  • LGND 48.65
  • JOE 4.00

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

About JOE St. Joe Company (The)

The St. Joe Co is a real estate development, asset management, and operating company and it has three operating segments; the Residential segment plans and develops residential communities and sells homesites to homebuilders or retail consumers, the Hospitality segment features a private membership club (the Watersound Club), hotel operations, food and beverage operations, golf courses, beach clubs, retail outlets, gulf-front vacation rentals, management services, marinas, and other entertainment assets, and Commercial segment include leasing of commercial property, multi-family, senior living, self-storage, and other assets and it also oversees the planning, development, entitlement, management, and sale of commercial and rural land holdings.

Share on Social Networks: